- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 182.54M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $521.36M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $522.44M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $5.5M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $5.5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $148.41M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $135.78M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $117.47M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $110.73M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $674.53M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $670.44M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $268.55M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $218.31M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.41B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.42B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 186.64M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $12.07M |
| Capex | Q1 2025 · Mar 31, 2024 | $402K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $13.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $800.69M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $826.04M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $31.64M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $19.31M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$16.32M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$4.3M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $137.85M |